In this issue... our top February share tips, company features, market insight & Aggressive Portfolio III.
Turning point for Circassia
AIM-listed Circassia Group (37.95p) has recently released final results for 2021 and these detailed positive adjusted EBITDA for the first time. The fact that this landmark has been reached may well attract more investors. Three significant shareholders, Richard Griffiths, Harwood Capital and AstraZeneca, own over 65% of the shares in issue between them, so any major buying interest is likely to see the share price push higher.
The company aims to improve the quality of life of those suffering from asthma…
CONTINUED IN THE FULL NEWSLETTER CLICK TO READ.
